CIMETIDINE DOES NOT ALTER SPARFLOXACIN PHARMACOKINETICS

被引:0
|
作者
GRIES, JM
HONORATO, J
TABURET, AM
ALVAREZ, MP
SADABA, B
AZANZA, JR
SINGLAS, E
机构
[1] UNIV NAVARRA,E-31080 PAMPLONA,SPAIN
[2] HOP NECKER ENFANTS MALAD,F-75015 PARIS,FRANCE
关键词
SPARFLOXACIN; CIMETIDINE; PHARMACOKINETICS; DRUG INTERACTION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interaction between cimetidine and sparfloxacin was studied in 10 healthy volunteers who received a single oral dose of 400 mg sparfloxacin on the third day of an 8 day cimetidine (400 mg t.i.d.) or placebo randomly assigned treatment. No statistically significant differences were observed in the pharmacokinetic parameters (C-max - AUC - T-1/2 - urinary excretion and metabolic ratio) of sparfloxacin following the 2 treatment. Cimetidine does not affect absorption, metabolism or urinary excretion of sparfloxacin; consequently, patients exposed to this drug combination are not at risk.
引用
收藏
页码:585 / 587
页数:3
相关论文
共 50 条
  • [1] Cimetidine does not alter atorvastatin pharmacokinetics or LDL-cholesterol reduction
    R. H. Stern
    D. M. Gibson
    L. R. Whitfield
    European Journal of Clinical Pharmacology, 1998, 53 : 475 - 478
  • [2] Cimetidine does not alter atorvastatin pharmacokinetics or LDL-cholesterol reduction
    Stern, RH
    Gibson, DM
    Whitfield, LR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 53 (06) : 475 - 478
  • [3] MOEXIPRIL DOES NOT ALTER THE PHARMACOKINETICS OR PHARMACODYNAMICS OF WARFARIN
    VANHECKEN, A
    VERBESSELT, R
    DEPRE, M
    TJANDRAMAGA, TB
    ANGEHRN, J
    CAWELLO, W
    DESCHEPPER, PJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (03) : 291 - 293
  • [4] Pharmacokinetics of sparfloxacin in patients with renal impairment
    Dorr, MB
    Johnson, RD
    Jensen, B
    Magner, D
    Marbury, T
    Talbo, GH
    CLINICAL THERAPEUTICS, 1999, 21 (07) : 1202 - 1215
  • [5] Sildenafil does not alter nelfinavir pharmacokinetics
    Bratt, G
    Ståhle, L
    THERAPEUTIC DRUG MONITORING, 2003, 25 (02) : 240 - 242
  • [6] BIOAVAILABILITY AND PHARMACOKINETICS OF CIMETIDINE
    GRAHNEN, A
    BAHR, CV
    LINDSTROM, B
    ROSEN, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (05) : 335 - 340
  • [7] LONG-TERM CIMETIDINE DOES NOT ALTER SERUM PROLACTIN
    HEALY, DL
    BURGER, HG
    KORMAN, MG
    STERN, A
    HORMONE RESEARCH, 1979, 11 (02) : 53 - 55
  • [8] CIMETIDINE DOES NOT ALTER THE CLEARANCE OR PLASMA-BINDING OF TENIDAP IN HEALTHY MALE-VOLUNTEERS
    WILNER, KD
    GARDNER, MJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 : S21 - S24
  • [9] STEREOSELECTIVE PHARMACOKINETICS OF DISOPYRAMIDE AND INTERACTION WITH CIMETIDINE
    BONDE, J
    PEDERSEN, LE
    NYGAARD, E
    RAMSING, T
    ANGELO, HR
    KAMPMANN, JP
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (06) : 708 - 710
  • [10] THE EFFECTS OF CIMETIDINE AND RANITIDINE ON THE PHARMACOKINETICS OF CIFENLINE
    MASSARELLA, JW
    DEFEO, TM
    LIGUORI, J
    PASSE, S
    AOGAICHI, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) : 481 - 483